Finally, a retrospective study of individuals receiving care from an American Medical Group Association (AMGA) member organisation found an A1c decrease of −1.13% among people with type 2 diabetes not on insulin therapy with a baseline A1c ≥ 7.5% [9]. This evidence concerns the gene INS and type 2 diabetes mellitus.